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DiGeorge syndrome/velo-cardio-facial syndrome (DGS/VCFS;
22q11.2 deletion syndrome) is the most common microdeletion
syndrome in humans with an estimated incidence of 1/4000. Typical
features of this syndrome are cardiovascular defects such as
interrupted aortic arch, outflow tract defects, thymus and parathyroid
hypo- or aplasia as well as submucous cleft palate. The TBX1 gene
within the 22q11.2 region deleted in affected individuals encodes a T-
box transcription factor. Heterozygosity of Tbx1, the mouse homo-
logue of TBX1, results in mild defects dependent on genetic
background, whereas complete inactivation results in severe mal-
formations in multiple tissues, indicating that embryonic develop-
ment is highly sensitive to Tbx1 gene dosage. We report here that loss
of function mutations in two Sprouty genes, which encode feedback
antagonists of receptor tyrosine kinase (RTK) signaling, phenocopy
many defects associated with the syndrome in the mouse. A stepwise
reduction of Sprouty gene dosage resulted in different phenotypes
emerging at specific steps, suggesting that the threshold up to which
a given developmental process can tolerate increased RTK signaling is
different. Tbx1 heterozygosity significantly exacerbated the severity
of all these defects, which correlated with a substantial increase in
RTK signaling. We conclude from these observations that TBX1
functions as an essential component of a buffering mechanism that
protects the embryo against perturbations in RTK signaling that may
lead to developmental defects characteristic of DGS/VCFS.
doi:10.1016/j.ydbio.2011.05.366
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Ciliopathies are developmental disorders that arise due to defects
in cilia biogenesis and function, and affect various sensory systems
including the auditory system. Involvement of multiple syndromic
ciliopathy genes, whose protein products are thought to function as
macromolecular complexes in both cilia and basal bodies, implicate
dynamic regulation of ciliary protein interactions. Mutations in
CEP290 (also known as NPHP6 or BBS14), have been found to cause
several ciliary disorders [Leber congenital amaurosis (LCA), Senior–
Loken syndrome, Joubert syndrome, nephronophthisis (NPHP),
Meckel–Gruber syndrome (MKS) and Bardet–Biedl syndrome
(BBS)]. Little is known about the function of CEP290, or how this
protein interacts with other cilia-related proteins complexes. An
initial finding of variants of MKKS (also known as BBS6) in LCA
patients led to an exploration of epistatic interactions between
CEP290 and MKKS. We found that the DSD domain of CEP290, which
is deleted in a mouse model (Cep290rd16) of LCA, directly interacts
with MKKS, and that pathogenic variants of MKKS disrupt this
interaction. Mice with either Cep290rd16/rd16 or Mkksko/ko geno-
types exhibit structural and functional auditory, photoreceptor, and
olfactory deficits. Unexpectedly, Cep290rd16/rd16; Mkksko/ko dou-
ble mutants actually show a degree of functional and/or morpholo-
gical rescue in all three sensory systems by comparison with either
single mutant. Morphological analysis suggests that improved
ciliogenesis forms the mechanistic basis for this functional rescue.
Our data demonstrate reciprocal modifier effects between the CEP290
DSD domain and MKKS that provides insight into the regulation of
cilia formation and function.
doi:10.1016/j.ydbio.2011.05.367
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Mutations in the human Shwachman–Bodian Diamond Syndrome
(SBDS) gene cause chronic neutropenia, exocrine pancreas dysfunc-
tion and skeletal defects. Although the precise cellular function of
SBDS is unknown, it has been implicated in ribosome biogenesis.
Diseases that affect ribosome biogenesis, termed ribosomopathies,
are generally understood to do so through a p53-dependent
mechanism. We used morpholino knock-down of the zebrafish
orthologue of SBDS to recapitulate the disease phenotype. Loss of
SBDS in zebrafish resulted in a loss of neutrophils, a small exocrine
pancreas and a disrupted skeletal architecture. Unlike other riboso-
mopathies, we have demonstrated that loss of p53 does not rescue
the SBDS MO mediated phenotype. We conclude Shwachman
Diamond Syndrome is a p53-independent ribosomopathy.
doi:10.1016/j.ydbio.2011.05.368
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BMP signaling as a context-dependent regulator of myocardial
proliferation and apoptosis: Relevance to congenital heart defects
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Acquired heart disease in adults is a leading cause of disability and
death, while cardiac malformations are a leading cause of prenatal
and neonatal death. Organogenesis of the heart involves a complex
contribution of multiple cell types from several sources, and the heart
must become functional well before its development is complete. An
understanding of the extracellular signals that regulate heart
development will help clarify how the heart is constructed, and
may prove useful in elucidating molecular pathways relevant to adult
heart disease and its treatment. We have used mouse models to
probe the roles of Bone Morphogenetic Protein (BMP) signaling in
heart development and disease. Several tissue-specific genetic
ablations and in vitro explant culture experiments demonstrate a
direct requirement for BMP signaling in regulating myocardial
differentiation and proliferation in extracardiac progenitors. Later,
BMP signaling is necessary within the heart for cardiomyocyte
proliferation. We further find that BMP antagonism by Noggin is
necessary to keep myocardial proliferation in check during embry-
ogenesis. Thus, BMP signaling and its antagonism balance myocardial
proliferation in the embryonic ventricles. In the adult heart, BMP
signaling increases in myocardium that has become ischemic upon
cardiac artery blockage (myocardial infarction). We find that BMP
promotes apoptosis in infarcted heart tissue. Genetic or pharmaco-
logical reduction of BMP activity reduces apoptosis and the extent
of myocardial damage after injury. Our findings shed new light on
the regulation of normal mammalian heart development and its
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